首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1304228

癌症化療誘發性噁心及嘔吐治療藥市場:各類型，各藥物類別，各給藥途徑，各流通管道，各地區:規模，佔有率，展望，機會分析，2023～2030年

Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type, By Drug Class, By Route of Administration, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年06月13日 | 出版商:

Coherent Market Insights | 英文 266 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場動態

化療引起的噁心和嘔吐（CINV）藥物用於接受化療的患者，以預防噁心和嘔吐。接受化療的患者數量的增加預計將在預測期內推動市場增長。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球癌症化療誘發性噁心及嘔吐治療藥市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球癌症化療誘發性噁心及嘔吐治療藥市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球癌症化療誘發性噁心及嘔吐治療藥市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球癌症化療誘發性噁心及嘔吐治療藥市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

Eisai Co., Ltd.
Pharmanovia
Novartis AG
Merck & Co., Inc.
Helsinn Healthcare SA
Reddy's Laboratories Ltd.
Validus Pharmaceuticals LLC
LGM Pharma
Astellas Pharma Inc.
AdvaCare Pharma
Norgine
PV Pharma
Fresenius Kabi
Lupin
Hetero Healthcare Limited.
Sino Biopharmaceutical Limited
Glenmark Pharmaceuticals Ltd.
Otsuka Pharmaceutical Co., Ltd
OPKO Health, Inc.
Weefsel Pharma
Pfizer Inc.
Rosemont Pharmaceuticals Ltd.
Starton Therapeutics

第11章章節

調查手法
關於出版社

簡介目錄

Product Code: CMI5823

Treatment for cancer patients must prioritize preventing and controlling nausea and vomiting (N&V). One of the most prevalent and upsetting acute adverse effects of chemotherapy-induced nausea and vomiting (N&V) is cancer treatment. It can significantly lower a patient's quality of life and happens in up to 80% of patients. The perceptual feeling of nausea is an unpleasant, wave-like sensation in the epigastrium and/or back of the throat that may lead to vomiting (emesis). Emesis, the violent evacuation of stomach, duodenal, or jejunal contents through the oral canal, is referred to as vomiting. Retching, also known as dry heaves, involves the stomach and esophageal motions of vomiting without the evacuation of vomitus. Understanding the neurophysiological systems that regulate nausea and vomiting (N&V) has advanced. The central nervous system regulates or mediates both, but through different ways. The autonomic nervous system is the mechanism that causes nausea.

A complicated response that includes the convergence of afferent input is stimulated during vomiting. Neurotransmitters in the chemoreceptor trigger zone, the vomiting center (said to be situated in the nucleus tractus solitarius), and enterochromaffin cells in the gastrointestinal tract emit efferent impulses. These neurotransmitters include serotonin, substance P, and dopamine. These signals are sent to the respiratory center, salivation center, and abdominal muscles. The relative importance of these several routes, which result in N&V symptoms, is complicated. It is proposed to explain agents' varying emetogenicity (intrinsic emetogenicity and mitigating variables [i.e., dose, administration method, and exposure length]) and emetogenic profile (i.e., time to onset, intensity, and duration of symptoms).

Market Dynamics

Chemotherapy-induced nausea and vomiting (CINV) drugs are given to patients who undergo chemotherapy treatment to prevent nausea and vomiting. An increase in the number of patients undergoing chemotherapy is expected to drive the market growth over the forecast period. For instance, according to the data provided by the Centers for Disease Control and Prevention, in November 2022, more than 1 million cancer patients receive chemotherapy or radiation in an outpatient oncology clinic in the U.S. each year.

Key features of the study:

This report provides an in-depth analysis of the global cancer chemotherapy associated nausea and vomiting therapeutics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer chemotherapy associated nausea and vomiting therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Eisai Co., Ltd., Pharmanovia, Novartis AG, Merck & Co., Inc., Helsinn Healthcare SA, Dr. Reddy's Laboratories Ltd., Validus Pharmaceuticals LLC, LGM Pharma, Astellas Pharma Inc., AdvaCare Pharma, Norgine, PV Pharma, Fresenius Kabi, Lupin, Hetero Healthcare Limited., Sino Biopharmaceutical Limited, Glenmark Pharmaceuticals Ltd., Otsuka Pharmaceutical Co., Ltd, OPKO Health, Inc., Weefsel Pharma, Pfizer Inc., Rosemont Pharmaceuticals Ltd., Starton Therapeutics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cancer chemotherapy associated nausea and vomiting therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer chemotherapy associated nausea and vomiting therapeutics market

Detailed Segmentation:

Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type:
- Acute CINV
- Delayed CINV
- Anticipatory nausea and emesis
- Breakthrough CINV/Refractory CINV
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Drug Class:
- Dopamine Receptor Antagonists
  - Metoclopramide
  - Chlorpromazine
  - Prochlorperazine
  - Haloperidol
  - Droperidol
  - Others
- Serotonin (5-HT3) receptor Antagonists
  - Ondansetron
  - Granisetron
  - Palonosetron
  - Dolasetron
  - Others
- Substance P/NK-1 Antagonists
  - Aprepitant
  - Fosaprepitant
  - Netupitant
  - Others
- Corticosteroids
  - Dexamethasone
  - Methylprednisolone
- Others
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Route of Administration:
- Oral
- Parenteral
- Transdermal Patch
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Regions
- South Africa
- Central Africa
- North Africa
Company Profiles
- Eisai Co., Ltd.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pharmanovia
- Novartis AG
- Merck & Co., Inc.
- Helsinn Healthcare SA
- Reddy's Laboratories Ltd.
- Validus Pharmaceuticals LLC
- LGM Pharma
- Astellas Pharma Inc.
- AdvaCare Pharma
- Norgine
- PV Pharma
- Fresenius Kabi
- Lupin
- Hetero Healthcare Limited.
- Sino Biopharmaceutical Limited
- Glenmark Pharmaceuticals Ltd.
- Otsuka Pharmaceutical Co., Ltd
- OPKO Health, Inc.
- Weefsel Pharma
- Pfizer Inc.
- Rosemont Pharmaceuticals Ltd.
- Starton Therapeutics.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Developments
PEST Analysis
PORTER's Analysis
Regulatory Scenario
Merger, Collaboration and Acquisition Scenario
Product Launches/Approvals
Epidemiology

4. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market- COVID-19 Impact Analysis

Economic Impact
Overall Impact on Healthcare Sector
COVID-19 Epidemiology

5. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type, 2018 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Acute CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Delayed CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Anticipatory nausea and emesis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Breakthrough CINV/Refractory CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Drug Class, 2018 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Dopamine Receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Metoclopramide
Chlorpromazine
Prochlorperazine
Haloperidol
Droperidol
Others
Serotonin (5-HT3) receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Ondansetron
Granisetron
Palonosetron
Dolasetron
Others
Substance P/NK-1 Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Aprepitant
Fosaprepitant
Netupitant
Others
Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Dexamethasone
Methylprednisolone
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Route of Administration, 2018 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Transdermal Patch
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Region, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Eisai Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pharmanovia
Novartis AG
Merck & Co., Inc.
Helsinn Healthcare SA
Reddy's Laboratories Ltd.
Validus Pharmaceuticals LLC
LGM Pharma
Astellas Pharma Inc.
AdvaCare Pharma
Norgine
PV Pharma
Fresenius Kabi
Lupin
Hetero Healthcare Limited.
Sino Biopharmaceutical Limited
Glenmark Pharmaceuticals Ltd.
Otsuka Pharmaceutical Co., Ltd
OPKO Health, Inc.
Weefsel Pharma
Pfizer Inc.
Rosemont Pharmaceuticals Ltd.
Starton Therapeutics

11. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

術後噁心嘔吐市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

噁心藥物市場：依藥物途徑、配銷通路和地區

FAQ

癌症化療誘發性噁心及嘔吐治療藥市場:各類型，各藥物類別，各給藥途徑，各流通管道，各地區:規模，佔有率，展望，機會分析，2023～2030年